{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:04:50Z","timestamp":1791018290689,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00511-6","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T03:48:48Z","timestamp":1764042528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The clinical spectrum of paediatric NF2- related schwannomatosis"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1098-8599","authenticated-orcid":false,"given":"Dorothy","family":"Halliday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Hanington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"9","key":"511_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmg-2024-110065","volume":"61","author":"C Forde","year":"2024","unstructured":"Forde C, Smith MJ, Burghel GJ, Bowers N, Roberts N, Lavin T, Halliday J, King AT, Rutherford S, Pathmanaban ON, Lloyd S, Freeman S, Halliday D, Parry A, Axon P, Buttimore J, Afridi S, Obholzer R, Laitt R, Thomas O, Stivaros SM, Vassallo G, Evans DG (2024) NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study. J Med Genet 61(9):856\u2013860. https:\/\/doi.org\/10.1136\/jmg-2024-110065","journal-title":"J Med Genet"},{"issue":"5","key":"511_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/archdischild-2017-313154","volume":"103","author":"G Anand","year":"2018","unstructured":"Anand G, Vasallo G, Spanou M, Thomas S, Pike M, Kariyawasam DS, Mehta S, Parry A, Durie-Gair J, Nicholson J, Lascelles K, Everett V, Gibbon FM, Jarvis N, Elston J, Evans DG, Halliday D (2018) Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population. Arch Dis Child 103(5):463\u2013469. https:\/\/doi.org\/10.1136\/archdischild-2017-313154","journal-title":"Arch Dis Child"},{"issue":"5","key":"511_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s004390050255","volume":"98","author":"L Kluwe","year":"1996","unstructured":"Kluwe L, Bayer S, Baser ME, Hazim W, Haase W, F\u00fcnsterer C, Mautner VF (1996) Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes. Hum Genet 98(5):534\u2013538. https:\/\/doi.org\/10.1007\/s004390050255","journal-title":"Hum Genet"},{"issue":"6","key":"511_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.35.6.450","volume":"35","author":"DG Evans","year":"1998","unstructured":"Evans DG, Trueman L, Wallace A, Collins S, Strachan T (1998) Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 35(6):450\u2013455. https:\/\/doi.org\/10.1136\/jmg.35.6.450","journal-title":"J Med Genet"},{"issue":"304","key":"511_CR5","first-page":"603","volume":"84","author":"DG Evans","year":"1992","unstructured":"Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84(304):603\u2013618","journal-title":"Q J Med"},{"issue":"4","key":"511_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajmg.1320520411","volume":"52","author":"DM Parry","year":"1994","unstructured":"Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52(4):450\u2013461. https:\/\/doi.org\/10.1002\/ajmg.1320520411","journal-title":"Am J Med Genet"},{"issue":"1","key":"511_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41436-019-0598-7","volume":"22","author":"DG Evans","year":"2020","unstructured":"Evans DG, Hartley CL, Smith PT, King AT, Bowers NL, Tobi S, Wallace AJ, Perry M, Anup R, Lloyd SKW, Rutherford SA, Hammerbeck-Ward C, Pathmanaban ON, Stapleton E, Freeman SR, Kellett M, Halliday D, Parry A, Gair JJ, Axon P, Laitt R, Thomas O, Afridi SK, Obholzer R, English Specialist NF research group, Duff C, Stivaros SM, Vassallo G, Harkness EF, Smith MJ (2020) Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing. Genet Med 22(1):53\u201359. https:\/\/doi.org\/10.1038\/s41436-019-0598-7","journal-title":"Genet Med"},{"issue":"1","key":"511_CR8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","volume":"23","author":"C Forde","year":"2021","unstructured":"Forde C, King AT, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SR, Pathmanaban ON, Stapleton E, Thomas OM, Laitt RD, Stivaros S, Kilday JP, Vassallo G, McBain C, Kerrigan S, Smith MJ, McCabe MG, Harkness EF, Evans DG (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro Oncol 23(1):1113\u20131124. https:\/\/doi.org\/10.1093\/neuonc\/noaa284","journal-title":"Neuro Oncol"},{"issue":"4","key":"511_CR9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/lary.27586","volume":"129","author":"B Emmanouil","year":"2019","unstructured":"Emmanouil B, Houston R, May A, Ramsden JD, Hanemann CO, Halliday D, Parry A, Mackeith S (2019) Progression of hearing loss in neurofibromatosis type 2 according to genetic severity. Laryngoscope 129(4):974\u2013980. https:\/\/doi.org\/10.1002\/lary.27586","journal-title":"Laryngoscope"},{"issue":"6","key":"511_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/adc.81.6.496","volume":"81","author":"DG Evans","year":"1999","unstructured":"Evans DG, Birch JM, Ramsden RT (1999) Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 81(6):496\u2013499. https:\/\/doi.org\/10.1136\/adc.81.6.496","journal-title":"Arch Dis Child"},{"issue":"10","key":"511_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H, Evans DG, Parry A (2017) Genetic severity score predicts clinical phenotype in NF2. J Med Genet 54(10):657\u2013664. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104519","journal-title":"J Med Genet"},{"issue":"10","key":"511_CR12","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s00381-020-04729-w","volume":"36","author":"I Gugel","year":"2020","unstructured":"Gugel I, Grimm F, Teuber C, Zipfel J, Tatagiba M, Mautner VF, Schuhmann MU, Kluwe L (2020) Presenting symptoms in children with neurofibromatosis type 2. Childs Nerv Syst 36(10):2463\u20132470. https:\/\/doi.org\/10.1007\/s00381-020-04729-w","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"511_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2005-837581","volume":"36","author":"M Ruggieri","year":"2005","unstructured":"Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36(1):21\u201334. https:\/\/doi.org\/10.1055\/s-2005-837581","journal-title":"Neuropediatrics"},{"issue":"21","key":"511_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02379-6","volume":"17","author":"S Legoupil","year":"2022","unstructured":"Legoupil S, Bessis D, Picard F, Mallet S, Mazereeuw J, Phan A, Dupin-Deguine D, Kalamarides M, Chiaverini C (2022) Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study. Orphanet J Rare Dis 17(21):242. https:\/\/doi.org\/10.1186\/s13023-022-02379-6","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"511_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jmg.2006.047753","volume":"44","author":"DG Evans","year":"2007","unstructured":"Evans DG, Ramsden RT, Shenton A, Gokhale C, Bowers NL, Huson SM, Pichert G, Wallace A (2007) Mosaicism in neurofibromatosis type 2: an update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet 44(7):424\u2013428. https:\/\/doi.org\/10.1136\/jmg.2006.047753","journal-title":"J Med Genet"},{"issue":"5","key":"511_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cge.14310","volume":"103","author":"D Halliday","year":"2023","unstructured":"Halliday D, Emmanouil B, Evans DGR (2023) Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis. Clin Genet 103(5):540\u2013552. https:\/\/doi.org\/10.1111\/cge.14310","journal-title":"Clin Genet"},{"issue":"1","key":"511_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1227\/00006123-199307000-00014","volume":"33","author":"VF Mautner","year":"1993","unstructured":"Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM (1993) Neurofibromatosis 2 in the pediatric age group. Neurosurgery 33(1):92\u201396. https:\/\/doi.org\/10.1227\/00006123-199307000-00014","journal-title":"Neurosurgery"},{"issue":"2","key":"511_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.braindev.2013.01.007","volume":"36","author":"M Matsuo","year":"2014","unstructured":"Matsuo M, Ohno K, Ohtsuka F (2014) Characterization of early onset neurofibromatosis type 2. Brain Dev 36(2):148\u2013152. https:\/\/doi.org\/10.1016\/j.braindev.2013.01.007","journal-title":"Brain Dev"},{"issue":"12","key":"511_CR19","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00381-016-3257-1","volume":"32","author":"N Bonne","year":"2016","unstructured":"Bonne N, Aboukais R, Baroncini M, Hochart A, Leblond P, Broly F, Dubrulle F, Lejeune JP, Vincent C (2016) Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation. Childs Nerv Syst 32(12):2403\u20132413. https:\/\/doi.org\/10.1007\/s00381-016-3257-1","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"511_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/cge.13551","volume":"96","author":"D Halliday","year":"2019","unstructured":"Halliday D, Emmanouil B, Vassallo G, Lascelles K, Nicholson J, Chandratre S, Anand G, Wasik M, Pretorius P, Evans DG, Parry A, English NF2 research group (2019) Trends in phenotype in the English paediatric neurofibromatosis type 2 cohort stratified by genetic severity. Clin Genet 96(2):151\u2013162. https:\/\/doi.org\/10.1111\/cge.13551","journal-title":"Clin Genet"},{"issue":"2","key":"511_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10048-013-0354-0","volume":"14","author":"M Ruggieri","year":"2013","unstructured":"Ruggieri M, Gabriele AL, Polizzi A, Salpietro V, Nicita F, Pavone P, Platania N, Milone P, Distefano A, Privitera G, Belfiore G, Granata F, Caltabiano R, Albanese V, Pavone L, Quattrone A (2013) Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics 14(2):89\u201398. https:\/\/doi.org\/10.1007\/s10048-013-0354-0","journal-title":"Neurogenetics"},{"issue":"1","key":"511_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/WNO.0000000000000675","volume":"39","author":"SL Painter","year":"2019","unstructured":"Painter SL, Sipkova Z, Emmanouil B, Halliday D, Parry A, Elston JS (2019) Neurofibromatosis type 2-related eye disease correlated with genetic severity type. J Neuroophthalmol 39(1):44\u201349. https:\/\/doi.org\/10.1097\/WNO.0000000000000675","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"511_CR23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","volume":"141","author":"MM Bosch","year":"2006","unstructured":"Bosch MM, Boltshauser E, Harpes P, Landau K (2006) Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 141(6):1068\u20131077. https:\/\/doi.org\/10.1016\/j.ajo.2005.12.042","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"511_CR24","doi-asserted-by":"publisher","first-page":"OCT262","DOI":"10.1167\/iovs.15-18919","volume":"57","author":"V Waisberg","year":"2016","unstructured":"Waisberg V, Rodrigues LO, Nehemy MB, Frasson M, de Miranda DM (2016) Spectral-domain optical coherence tomography findings in neurofibromatosis type 2. Invest Ophthalmol Vis Sci 57(9):OCT262\u2013OCT267. https:\/\/doi.org\/10.1167\/iovs.15-18919","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"511_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/13816810.2025.2458751","volume":"46","author":"MH Berry","year":"2025","unstructured":"Berry MH, Skanchy DF, Archer SM, Mingardo F, Elner V, Demirci H (2025) Unusual fundus lesion in mosaic neurofibromatosis type 2. Ophthalmic Genet 46(2):211\u2013214. https:\/\/doi.org\/10.1080\/13816810.2025.2458751","journal-title":"Ophthalmic Genet"},{"key":"511_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jocn.2018.01.012","volume":"50","author":"V Jayanetti","year":"2018","unstructured":"Jayanetti V, Klistorner AI, Graham SL, Dexter M, Flaherty MP, Jones K, Billson FA, Wilson M, North K, Grigg JR, Fraser CL (2018) Monitoring of optic nerve function in Neurofibromatosis 2 children with optic nerve sheath meningiomas using multifocal visual evoked potentials. J Clin Neurosci 50:262\u2013267. https:\/\/doi.org\/10.1016\/j.jocn.2018.01.012","journal-title":"J Clin Neurosci"},{"issue":"1","key":"511_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000519143","volume":"65","author":"B Emmanouil","year":"2022","unstructured":"Emmanouil B, Wasik M, Charbel Issa P, Halliday D, Parry A, Sharma SM (2022) Structural abnormalities of the central retina in neurofibromatosis type 2. Ophthalmic Res 65(1):77\u201385. https:\/\/doi.org\/10.1159\/000519143","journal-title":"Ophthalmic Res"},{"issue":"5","key":"511_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.pcl.2010.07.002","volume":"57","author":"KN Shah","year":"2010","unstructured":"Shah KN (2010) The diagnostic and clinical significance of caf\u00e9-au-lait macules. Pediatr Clin North Am 57(5):1131\u20131153. https:\/\/doi.org\/10.1016\/j.pcl.2010.07.002","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"511_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s0022-3476(96)70066-5","volume":"129","author":"SL Vanderhooft","year":"1996","unstructured":"Vanderhooft SL, Francis JS, Pagon RA, Smith LT, Sybert VP (1996) Prevalence of hypopigmented macules in a healthy population. J Pediatr 129(3):355\u2013361. https:\/\/doi.org\/10.1016\/s0022-3476(96)70066-5","journal-title":"J Pediatr"},{"key":"511_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092355","volume":"20","author":"I Gugel","year":"2020","unstructured":"Gugel I, Grimm F, Zipfel J, Teuber C, Ernemann U, Kluwe L, Tatagiba M, Mautner VF, Schuhmann MU (2020) Age at onset and presenting symptoms of Neurofibromatosis type 2 as prognostic factors for clinical course of vestibular schwannomas. Cancers (Basel) 20:2355. https:\/\/doi.org\/10.3390\/cancers12092355","journal-title":"Cancers (Basel)"},{"issue":"1","key":"511_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-010-0503-3","volume":"104","author":"RS Kotecha","year":"2011","unstructured":"Kotecha RS, Junckerstorff RC, Lee S, Cole CH, Gottardo NG (2011) Pediatric meningioma: current approaches and future direction. J Neurooncol 104(1):1\u201310. https:\/\/doi.org\/10.1007\/s11060-010-0503-3","journal-title":"J Neurooncol"},{"issue":"11","key":"511_CR32","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00381-012-1823-8","volume":"28","author":"MV Santos","year":"2012","unstructured":"Santos MV, Furlanetti L, Valera ET, Brassesco MS, Tone LG, de Oliveira RS (2012) Pediatric meningiomas: a single-center experience with 15 consecutive cases and review of the literature. Childs Nerv Syst 28(11):1887\u20131896. https:\/\/doi.org\/10.1007\/s00381-012-1823-8","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"511_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-024-06708-x","volume":"41","author":"F Grilli","year":"2024","unstructured":"Grilli F, Smaili HY, Bianchi F, Frassanito P, Tamburrini G, Massimi L (2024) Hyperostotic meningiomas in children. A case-based update. Childs Nerv Syst 41(1):43. https:\/\/doi.org\/10.1007\/s00381-024-06708-x","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"511_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12024-024-00867-8","volume":"21","author":"K Sakai","year":"2025","unstructured":"Sakai K, Hayashi K (2025) Death in a bathtub of an adolescent with neurofibromatosis type 2 exhibiting meningioangiomatosis with white matter involvement. Forensic Sci Med Pathol 21(1):283\u2013289. https:\/\/doi.org\/10.1007\/s12024-024-00867-8","journal-title":"Forensic Sci Med Pathol"},{"key":"511_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nicl.2013.12.010","volume":"4","author":"WS Vargas","year":"2014","unstructured":"Vargas WS, Heier LA, Rodriguez F, Bergner A, Yohay K (2014) Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2. Neuroimage Clin 4:258\u2013265. https:\/\/doi.org\/10.1016\/j.nicl.2013.12.010","journal-title":"Neuroimage Clin"},{"issue":"4","key":"511_CR36","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.radcr.2022.01.050","volume":"17","author":"A Wheeler","year":"2022","unstructured":"Wheeler A, Metrock K, Li R, Singh S (2022) Cystic meningioangiomatosis and cerebellar ependymoma in a child with neurofibromatosis type 2. Radiol Case Rep 17(4):1082\u20131087. https:\/\/doi.org\/10.1016\/j.radcr.2022.01.050","journal-title":"Radiol Case Rep"},{"issue":"1","key":"511_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpn.2008.02.007","volume":"13","author":"J Ng","year":"2009","unstructured":"Ng J, Mordekar SR, Connolly DJ, Baxter P (2009) Stroke in a child with neurofibromatosis type 2. Eur J Paediatr Neurol 13(1):77\u201379. https:\/\/doi.org\/10.1016\/j.ejpn.2008.02.007","journal-title":"Eur J Paediatr Neurol"},{"issue":"12","key":"511_CR38","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/dmcn.13920","volume":"60","author":"K Lascelles","year":"2018","unstructured":"Lascelles K, Afridi S, Siddiqui A, Hemingway C, Ferner R, Ganesan V (2018) Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern? Dev Med Child Neurol 60(12):1285\u20131288. https:\/\/doi.org\/10.1111\/dmcn.13920","journal-title":"Dev Med Child Neurol"},{"key":"511_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00733","volume":"9","author":"I Gugel","year":"2018","unstructured":"Gugel I, Mautner VF, Kluwe L, Tatagiba MS, Schuhmann MU (2018) Cerebrovascular insult as presenting symptom of neurofibromatosis type 2 in children, adolescents, and young adults. Front Neurol 9:733. https:\/\/doi.org\/10.3389\/fneur.2018.00733","journal-title":"Front Neurol"},{"issue":"4","key":"511_CR40","first-page":"163","volume":"76","author":"A Trautman","year":"2023","unstructured":"Trautman A, Sandhu D (2023) Ischemic cerebellar stroke in a young patient with neurofibromatosis type 2: a case report. S D Med 76(4):163\u2013166","journal-title":"S D Med"},{"issue":"1","key":"511_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5137\/1019-5149.JTN.8104-13.0","volume":"24","author":"L Wu","year":"2014","unstructured":"Wu L, Deng X, Yang C, Xu Y (2014) Spinal intradural malignant peripheral nerve sheath tumor in a child with neurofibromatosis type 2: the first reported case and literature review. Turk Neurosurg 24(1):135\u2013139. https:\/\/doi.org\/10.5137\/1019-5149.JTN.8104-13.0","journal-title":"Turk Neurosurg"},{"issue":"1","key":"511_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/neuros\/nyx368","volume":"83","author":"AT King","year":"2018","unstructured":"King AT, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SR, Pathmanaban ON, Kellett M, Obholzer R, Afridi S, Axon P, Halliday D, Parry A, Thomas OM, Laitt RD, McCabe MG, Stivaros S, Erridge S, Evans DG, English Specialist NF2 research group (2018) Malignant peripheral nerve sheath tumors are not a feature of neurofibromatosis type 2 in the unirradiated patient. Neurosurgery 83(1):38\u201342. https:\/\/doi.org\/10.1093\/neuros\/nyx368","journal-title":"Neurosurgery"},{"issue":"1","key":"511_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/crpe\/7680840","volume":"2024","author":"B Hafez","year":"2024","unstructured":"Hafez B, Alwan JS, El Hout W, Koussa K, El Annan T, Noun D, Zaghal A (2024) Neurofibromatosis type 2 presenting as symptomatic gallbladder hydrops: a rare case report and literature review. Case Rep Pediatr 2024(1):7680840. https:\/\/doi.org\/10.1155\/crpe\/7680840","journal-title":"Case Rep Pediatr"},{"key":"511_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9814591","volume":"2018","author":"SM Amer","year":"2018","unstructured":"Amer SM, Ukudeyeva A, Pine HS, Campbell GA, Clement CG (2018) Plexiform schwannoma of the tongue in a pediatric patient with neurofibromatosis type 2: a case report and review of literature. Case Rep Pathol 2018:9814591. https:\/\/doi.org\/10.1155\/2018\/9814591","journal-title":"Case Rep Pathol"},{"key":"511_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2021.12.004","volume":"262","author":"C Kotch","year":"2022","unstructured":"Kotch C, Fisher MJ, Lin F, Zhong Y, Gallo D, Fan Z, Chen J, Santi M, Li MM (2022) Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: a novel dual diagnosis. Cancer Genet 262:1\u20134. https:\/\/doi.org\/10.1016\/j.cancergen.2021.12.004","journal-title":"Cancer Genet"},{"key":"511_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-13-19","volume":"13","author":"TB Davidson","year":"2012","unstructured":"Davidson TB, Sanchez-Lara PA, Randolph LM, Krieger MD, Wu SQ, Panigrahy A, Shimada H, Erdreich-Epstein A (2012) Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature. BMC Med Genet 13:19. https:\/\/doi.org\/10.1186\/1471-2350-13-19","journal-title":"BMC Med Genet"},{"issue":"7","key":"511_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2023.104773","volume":"66","author":"SA Koza","year":"2023","unstructured":"Koza SA, Tabet AC, Bonaglia MC, Andres S, Anderlid BM, Aten E, Stiefsohn D, European Phelan-McDermid syndrome consortium, Evans DG, van Ravenswaaij-Arts CMA, Kant SG (2023) Consensus recommendations on counselling in Phelan-McDermid syndrome, with special attention to recurrence risk and to ring chromosome 22. Eur J Med Genet 66(7):104773. https:\/\/doi.org\/10.1016\/j.ejmg.2023.104773","journal-title":"Eur J Med Genet"},{"issue":"7","key":"511_CR48","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/pon.5099","volume":"28","author":"LM Quarmby","year":"2019","unstructured":"Quarmby LM, Dalton LJ, Woolrich RA, Clarke R, Emmanouil B, Patel S, Rands G, Parry A, Halliday D (2019) Screening and intervening: psychological distress in neurofibromatosis type 2 (NF2). Psychooncology 28(7):1583\u20131587. https:\/\/doi.org\/10.1002\/pon.5099","journal-title":"Psychooncology"},{"issue":"1","key":"511_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/13548506.2010.516363","volume":"16","author":"CM Patel","year":"2011","unstructured":"Patel CM, Ferner R, Grunfeld EA (2011) A qualitative study of the impact of living with neurofibromatosis type 2. Psychol Health Med 16(1):19\u201328. https:\/\/doi.org\/10.1080\/13548506.2010.516363","journal-title":"Psychol Health Med"},{"issue":"2","key":"511_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11060-020-03441-8","volume":"147","author":"EG Lester","year":"2020","unstructured":"Lester EG, Macklin EA, Plotkin S, Vranceanu AM (2020) Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program. J Neurooncol 147(2):451\u2013457. https:\/\/doi.org\/10.1007\/s11060-020-03441-8","journal-title":"J Neurooncol"},{"issue":"5","key":"511_CR51","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuchi.2015.10.006","volume":"64","author":"SK Lloyd","year":"2018","unstructured":"Lloyd SK, Evans DG (2018) Neurofibromatosis type 2 service delivery in England. Neurochirurgie 64(5):375\u2013380. https:\/\/doi.org\/10.1016\/j.neuchi.2015.10.006","journal-title":"Neurochirurgie"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00511-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:17:33Z","timestamp":1765009053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00511-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00511-6","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"89"}}